Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan
14 mars 2019 08h00 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across...
Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results
13 févr. 2019 06h40 HE
|
Cambrex Corporation
- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base - - Conference call at 8:30 a.m. ET on February 13, 2019 - EAST RUTHERFORD, N.J.,...
Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019
08 févr. 2019 15h47 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Completes Acquisition of Avista Pharma Solutions
02 janv. 2019 09h40 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and...
Cambrex Expands Analytical Capabilities at its High Point, NC Site
11 déc. 2018 10h32 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
20 nov. 2018 06h40 HE
|
Cambrex Corporation
-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and...
Cambrex Reports Third Quarter 2018 Financial Results
08 nov. 2018 06h40 HE
|
Cambrex Corporation
- Acquired Halo Pharma, broadening capabilities, enhancing revenue growth and expanding customer base - - Conference call at 8:30 a.m. ET on November 8, 2018 - EAST RUTHERFORD, N.J., Nov. 08, 2018 ...
Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
05 nov. 2018 15h55 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
08 oct. 2018 08h00 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply
25 sept. 2018 10h25 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...